New Simons VIP Phase 2 data were recently added to SFARI Base. This data release included data from individuals with 16p11.2 copy number variants (CNVs), 1q21.1 CNVs and mutations in the following single genes: ADNP, ASXL3, DYRK1A, FOXP1, GRIN2B, HIVEP2, MED13L, PACS1, PPP2R5D, SCN2A, STXBP1 and SYNGAP1.
SFARI announces the launch of HumanBase, a Simons Foundation interactive web server for predictions and information about human genes, pathways and disorders.
SPARK’s first year: A new paper describes goals and milestones SFARI announces that a new article summarizing the first year’s activities of SPARK — a SFARI-funded study that aims to recruit, engage and retain 50,000 individuals with autism spectrum disorder (ASD) and their family members — was published in the journal Neuron.
Third-party gene scores added to SFARI Gene SFARI is happy to announce a new addition to the gene-scoring module of SFARI Gene: scores and rankings from an additional six published approaches to evaluating the strength of the evidence implicating each gene in autism risk.
SFARI 2017 Explorer awardees announced SFARI is pleased to announce that it has awarded 13 grants in response to the Explorer Awards request for applications this year.
SFARI announces 2017 Bridge to Independence Award finalists SFARI is pleased to announce that it has selected seven finalists in response to the 2017 Bridge to Independence Award request for applications.